Cargando…

High out‑of‑pocket spending and financial hardship at the end of life among cancer survivors and their families

Cancer is one of the most expensive medical conditions to treat worldwide, affecting national and local spending, as well as household budgets for patients and their families. In this commentary about a recent paper from Tur‑Sinai et al., we discuss the high out-of-pocket spending and medical and no...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jingxuan, Yabroff, K. Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324154/
https://www.ncbi.nlm.nih.gov/pubmed/37415261
http://dx.doi.org/10.1186/s13584-023-00572-x
_version_ 1785069089054523392
author Zhao, Jingxuan
Yabroff, K. Robin
author_facet Zhao, Jingxuan
Yabroff, K. Robin
author_sort Zhao, Jingxuan
collection PubMed
description Cancer is one of the most expensive medical conditions to treat worldwide, affecting national and local spending, as well as household budgets for patients and their families. In this commentary about a recent paper from Tur‑Sinai et al., we discuss the high out-of-pocket spending and medical and non-medical financial hardship faced by cancer patients and their families at the end-of-life in Israel. We provide recent information about the costs of health care in Israel and other high-income countries with (i.e., Canada, Australia, Japan, and Italy) and without universal health insurance coverage (i.e., United States, a country with high healthcare costs and uninsurance rate), and highlight the role of improving health insurance coverage and benefit design in reducing financial hardship among cancer patients and their families. Recognizing that financial hardship at the end of life affects both patients and their families, developing comprehensive programs and policies in Israel as well as in other countries is warranted.
format Online
Article
Text
id pubmed-10324154
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103241542023-07-07 High out‑of‑pocket spending and financial hardship at the end of life among cancer survivors and their families Zhao, Jingxuan Yabroff, K. Robin Isr J Health Policy Res Commentary Cancer is one of the most expensive medical conditions to treat worldwide, affecting national and local spending, as well as household budgets for patients and their families. In this commentary about a recent paper from Tur‑Sinai et al., we discuss the high out-of-pocket spending and medical and non-medical financial hardship faced by cancer patients and their families at the end-of-life in Israel. We provide recent information about the costs of health care in Israel and other high-income countries with (i.e., Canada, Australia, Japan, and Italy) and without universal health insurance coverage (i.e., United States, a country with high healthcare costs and uninsurance rate), and highlight the role of improving health insurance coverage and benefit design in reducing financial hardship among cancer patients and their families. Recognizing that financial hardship at the end of life affects both patients and their families, developing comprehensive programs and policies in Israel as well as in other countries is warranted. BioMed Central 2023-07-06 /pmc/articles/PMC10324154/ /pubmed/37415261 http://dx.doi.org/10.1186/s13584-023-00572-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Commentary
Zhao, Jingxuan
Yabroff, K. Robin
High out‑of‑pocket spending and financial hardship at the end of life among cancer survivors and their families
title High out‑of‑pocket spending and financial hardship at the end of life among cancer survivors and their families
title_full High out‑of‑pocket spending and financial hardship at the end of life among cancer survivors and their families
title_fullStr High out‑of‑pocket spending and financial hardship at the end of life among cancer survivors and their families
title_full_unstemmed High out‑of‑pocket spending and financial hardship at the end of life among cancer survivors and their families
title_short High out‑of‑pocket spending and financial hardship at the end of life among cancer survivors and their families
title_sort high out‑of‑pocket spending and financial hardship at the end of life among cancer survivors and their families
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324154/
https://www.ncbi.nlm.nih.gov/pubmed/37415261
http://dx.doi.org/10.1186/s13584-023-00572-x
work_keys_str_mv AT zhaojingxuan highoutofpocketspendingandfinancialhardshipattheendoflifeamongcancersurvivorsandtheirfamilies
AT yabroffkrobin highoutofpocketspendingandfinancialhardshipattheendoflifeamongcancersurvivorsandtheirfamilies